Patients will be able to find out whether they have genes linked to cancer using a world-leading tool developed by the NHS.

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...

A nationwide Australian pilot screened more than 10,000 adults aged 18–40 years for high-risk genetic variants linked to ...

Medicare-eligible patients with advanced cancers will have access to genomic tests under a national coverage determination CMS finalized March 16. The determination covers next-generation sequencing ...

A new AI model from Google DeepMind called AlphaGenome can predict how DNA mutations affect biological processes, helping pinpoint genes linked to diseases and speeding up drug discovery.

Providing patient-centered education and navigation support significantly increases consent rates for genomic testing, making ...

Breast cancer is the most common cancer among women, making up 30% of all new cases each year. Knowledge is power when it comes to detection and prevention of this disease: Genetic testing can play an ...

An emerging oncology tool known as broad genomic profiling or BGP is increasingly being used to help identify targeted therapies for patients diagnosed with cancer. Rather than analyzing one gene at a ...

Leading genomic health experts from Monash University are calling for urgent government funding to progress the development ...

They include the “Jolie” gene, named after actress Angelina Jolie, who had preventative surgery after finding out she had a ...

Komen(R) , the world's leading breast cancer organization, commends Representative Rick Scarbrough (R-Oak Ridge) and Senator Richard Briggs (R-Knoxville) for introducing legislation that would ...

In 2023, Jill Martin took a test that changed her life. She underwent genetic testing for breast cancer and learned she had a BRCA2 mutation, which increases one’s risk of developing breast and other ...